Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

BMS-986166

2 clinical trials

3 indications

Indication
Dermatitis
Indication
Atopic
Indication
Healthy Participants
Clinical trial
A Phase 2, Randomized, Double-blinded, Placebo-controlled, 5 Parallel-group Study of BMS-986166 or Branebrutinib for the Treatment of Patients With Moderate to Severe Atopic Dermatitis
Status: Completed, Estimated PCD: 2022-08-22
Clinical trial
A Phase 1, Single-center, Open-label Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of [14C] BMS-986166 in Healthy Male Participants
Status: Completed, Estimated PCD: 2022-10-15